Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Postprandial Hyperglycemia on Arterial Stiffness in T2DM
NCT01159938Phase 4Completed
- Sponsor
- Eli Lilly and Company
- Start
- Oct 2010
- Primary completion
- Feb 2013
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, open-label trial of insulin lispro in type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Eli Lilly and Company. Primary endpoint: Postprandial Pulse Wave Velocity. Started Oct 2010; status: completed.
02
Drugs
insulin lispro
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT01159938.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01159938.